HomeBusinessBudget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical...

Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned – The Economic Times Video

Finance Minister Nirmala Sitharaman on Sunday announced a Rs 10,000 crore outlay for the Bio Pharma Shakti scheme for biologics and biosimilar drugs to make India a global bio-pharma hub. Presenting the Budget 2026-27, she said these bio medicines would help the country tackle the growing burden of non-communicable diseases like diabetes. The Finance Minister also said that the government would create 1 lakh Allied Health Professionals (AHPs) in 10 disciplines like optometry, radiology, and anaesthesia over the next five years as part of the Budget proposals.

Show more

Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments